VSeq-Toolkit: Comprehensive Computational Analysis of Viral Vectors in Gene Therapy
暂无分享,去创建一个
Raffaele Fronza | Saira Afzal | Manfred Schmidt | R. Fronza | Manfred Schmidt | S. Afzal | M. Schmidt
[1] Paola Bonizzoni,et al. γ-TRIS: a graph-algorithm for comprehensive identification of vector genomic insertion sites , 2019, Bioinform..
[2] Martin J. Aryee,et al. High levels of AAV vector integration into CRISPR-induced DNA breaks , 2019, Nature Communications.
[3] S. Freeman,et al. Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa , 2019, International Journal of Retina and Vitreous.
[4] D. Grimm,et al. AAV vector-mediated in vivo reprogramming into pluripotency , 2018, Nature Communications.
[5] E. Steinhagen-Thiessen,et al. Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions. , 2018, Human gene therapy.
[6] G. Ronzitti,et al. Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.
[7] L. Milanesi,et al. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites , 2017, BMC Bioinformatics.
[8] Surbhi Jain,et al. ChimericSeq: An open-source, user-friendly interface for analyzing NGS data to identify and characterize viral-host chimeric sequences , 2017, PloS one.
[9] J. Glorioso,et al. A brief account of viral vectors and their promise for gene therapy , 2017, Gene Therapy.
[10] Kyle Bittinger,et al. INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions , 2016, Molecular therapy. Methods & clinical development.
[11] Christof von Kalle,et al. GENE-IS: Time-Efficient and Accurate Analysis of Viral Integration Events in Large-Scale Gene Therapy Data , 2016, Molecular therapy. Nucleic acids.
[12] A. Zamyatnin,et al. Viral vectors for gene therapy: Current state and clinical perspectives , 2016, Biochemistry (Moscow).
[13] Johannes C. M. van der Loo,et al. Progress and challenges in viral vector manufacturing. , 2016, Human molecular genetics.
[14] O. Merten,et al. Towards routine manufacturing of gene therapy drugs , 2016, Molecular therapy. Methods & clinical development.
[15] Luigi Naldini,et al. Gene therapy returns to centre stage , 2015, Nature.
[16] S. Szymczak,et al. Vy-PER: eliminating false positive detection of virus integration events in next generation sequencing data , 2015, Scientific Reports.
[17] Daniel G. Miller,et al. VISA - Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing , 2015, BMC Bioinformatics.
[18] Daniel Ho,et al. Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability , 2015, Oncotarget.
[19] C. von Kalle,et al. Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease , 2014, Current gene therapy.
[20] Shuifang Zhu,et al. Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads , 2014, BMC Bioinformatics.
[21] F. Cremers,et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.
[22] C. von Kalle,et al. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.
[23] Adam Bagg,et al. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. , 2013, Blood.
[24] Zhongming Zhao,et al. VirusFinder: Software for Efficient and Accurate Detection of Viruses and Their Integration Sites in Host Genomes through Next Generation Sequencing Data , 2013, PloS one.
[25] John N. Weinstein,et al. VirusSeq: software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue , 2013, Bioinform..
[26] Christof von Kalle,et al. Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] Christof von Kalle,et al. Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites. , 2012, Human gene therapy methods.
[28] Chuanfeng Wu,et al. Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity , 2011, Frontiers of medicine.
[29] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[30] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[31] Christine Kinnon,et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.
[32] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[33] Hanno Glimm,et al. High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.
[34] W. Godbey,et al. Viral vectors for gene delivery in tissue engineering. , 2006, Advanced drug delivery reviews.
[35] J. B. Connolly,et al. Lentiviruses in gene therapy clinical research , 2002, Gene Therapy.
[36] Claude-Alain H. Roten,et al. Theoretical and practical advances in genome halving , 2004 .